Nucleo CMP Forte capsules

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

cytidine-5-disodium monophosphate + (uridine-5-trisodium triphosphate, uridine-5-disodium diphosphate, uridine-5-disodium monophosphate)

Доступна с:

Ferrer International

код АТС:

առկա չէ (N07XX)

ИНН (Международная Имя):

cytidine-5-disodium monophosphate + (uridine-5-trisodium triphosphate, uridine-5-disodium diphosphate, uridine-5-disodium monophosphate)

дозировка:

5mg+ 3mg

Фармацевтическая форма:

capsules

Штук в упаковке:

(30/2x15/) blisters

Тип рецепта:

OTC

Статус Авторизация:

Registered

Дата Авторизация:

2018-04-17

Характеристики продукта

NUCLEO CMP FORTE CAPSULES
SUMMARY PRODUCT CHARACTERISTICS
1. NAME OF THE MEDICINAL PRODUCT:
NUCLEO CMP FORTE capsules
2. QUALITATIVE AND QUANTITATIVE COMPOSITION.
Composition:
Per capsule:
Cytidine-5’-disodium monophosphate (CMP disodium salt)… 5 mg
Uridine-5’-trisodium triphosphate (UTP trisodium salt)
Uridine-5’-disodium diphosphate (UDP disodium salt)
Uridine-5’-disodium monophosphate (UMP disodium salt)
on the whole ………………………………… 3 mg
(equivalent to 1.330 mg of Uridine )
3. PHARMACEUTICAL FORM:
-
30
capsules
with
blue-coloured
head
and
grey
body
containing
a
white
and
hygroscopic powder.
4. CLINICAL PARTICULARS:
4.1. THERAPEUTICAL INDICATIONS:
Treatment
of
neuropathies
of
osteoarticular
(sciatica,
radiculitis,
etc.),
metabolic
(diabetic, alcoholic polyneuritis, etc.), infectious (herpes zoster)
origin, and a frigore.
Neuralgia of the Facial, Trigeminal, Intercostal, Lumbago.
4.2. POSOLOGY AND METHOD OF ADMINISTRATION:
- Nucleo CMP Forte capsules is administered by oral route.
Dosage:
Adults: 1 or 2 capsules 2 times daily.
Children: 1 capsule 2 times daily. As prescribed by physician.
4.3. CONTRAINDICATIONS:
Not known. Unless that there exists an allergy to any of the
components.
4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE:
Not applicable
4.5. INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION:
Not known.
4.6. PREGNANCY AND LACTATION:
Its use during pregnancy is not contraindicated. However, it is
recommended that the
dosage pattern is established by the physician.
4.7. EFFECTS ON THE ABILITY TO DRIVE AND USE MACHINES
Not applicable
4.8. UNDESIRABLE EFFECTS:
Have not been described, but if any adverse reaction attributable to
the taking of the
medicament appears, consult your physician or pharmacist.
4.9. OVERDOSE:
Given the scarce toxicity of the preparation, poisoning is not
foreseen, even by accident.
5. PHARMACOLOGICAL PROPERTIES
5.1. PHARMACODYNAMIC PROPERTIES:
ATC CODE N07XX (OTHER NERVOUS SYSTEM DRUGS)
NUCLEO CMP FORTE is an association of nuc